• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ZeinCRO expands to 14 CSEE countries total

ZeinCRO expands to 14 CSEE countries total

December 18, 2012
CenterWatch Staff

ZeinCRO, a CRO based in Europe, has reinforced its position in Central- and South- Eastern Europe (CSEE), with the opening of offices in 5 additional countries, extending its reach to 14 countries in total.

 In addition to its established presence in Cyprus, Greece, Hungary, Romania and Turkey, ZeinCRO now has offices in Bulgaria, Czech Republic, Estonia, FYROM and Poland. With an expanded workforce of more than 200 and over a decade’s operational experience, ZeinCRO is now positioned to offer its global drug development customers clinical trial services in 14 countries—including Latvia, Lithuania, Moldova and Slovakia—that cover the majority of the geographical regions of CSEE and provide access to a population of 250 million people.

 “Our extensive experience in providing specialist clinical services has taught us that, in order to gain a thorough understanding of a particular community and to forge long-lasting relationships with authorities and healthcare professionals, we need to establish local presence,” said Gregory Sivolapenko, chairman of ZeinCRO. “Our expansion in these additional countries underlines our efforts to set new standards for successful clinical trials and become the leading single provider of clinical research in the CSEE region.”

 ZeinCRO delivers bespoke clinical research services that are flexible and ethical, maximizing patient recruitment and compliance. In addition to clinical research services, ZeinCRO provides additional services in the areas of post-marketing safety and efficacy studies, regulatory affairs and pharmacovigilance including risk management plans.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing